ACHL

Achilles Therapeutics PLC Sponsored ADR · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website achillestx.com
Employees(FY) 234
ISIN US00449L1026

Performance

+22.52%

1W

+9.26%

1M

-0.12%

3M

+11.18%

6M

+3.36%

YTD

-4.29%

1Y

Profile

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Advanced Technical Analysis

Technical Analysis of ACHL 2024-05-03

Overview:

In analyzing the technical indicators for ACHL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...

See more ...

Recent News & Updates

2024-05-08 01:53
ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024(Investorplace)
2024-05-07 19:00
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights(Globenewswire)
2024-04-03 23:53
ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023(Investorplace)
2024-04-03 18:45
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights(Globenewswire)
2024-04-03 18:30
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning(Globenewswire)
2024-02-04 18:00
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference(Globenewswire)
2023-12-17 18:00
Achilles Therapeutics Announces Publication of Nature Cancer 'Comment' on Strategy for Improved Neoantigen Immunogenicity Prediction(Globenewswire)
2023-11-13 03:30
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights(Globenewswire)
2023-10-24 00:30
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis(Yahoo Finance)
2023-09-22 04:30
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement(Yahoo Finance)
2023-09-21 21:40
Are Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?(Yahoo Finance)
2023-09-13 00:05
Waters (WAT) Walk-Up Solutions Boost Bioprocess Development(Yahoo Finance)
2023-09-05 21:40
Is KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?(Yahoo Finance)
2023-08-09 23:50
Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View(Yahoo Finance)
2023-08-03 19:00
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights(Yahoo Finance)
2023-06-11 20:00
Achilles Therapeutics to Present at Upcoming Conferences(Yahoo Finance)
2023-05-20 22:03
3 Stocks With 1,000% Upside Potential(Yahoo Finance)
2023-05-09 19:15
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights(Yahoo Finance)
2023-05-09 19:00
Achilles Therapeutics New Immunogenicity Prediction Application of its AI-Powered PELEUS Platform Uniquely Identifies the Most Potent T Cell Antigens(Yahoo Finance)
2023-04-25 06:00
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement(Yahoo Finance)
2023-04-24 19:00
Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status(Yahoo Finance)
2023-04-21 21:45
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?(Yahoo Finance)
2023-04-16 20:00
Achilles Therapeutics to Present at Chardans 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit(Yahoo Finance)
2023-03-06 18:00
Achilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business Highlights(Yahoo Finance)
2023-02-01 20:40
Is Achilles Therapeutics (ACHL) Outperforming Other Medical Stocks This Year?(Yahoo Finance)
2023-01-16 20:40
Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?(Yahoo Finance)
2022-12-19 19:30
Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference(Yahoo Finance)
2022-12-05 17:00
Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022(Yahoo Finance)
2022-11-30 05:05
Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022(Yahoo Finance)
2022-11-21 19:00
Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method(Yahoo Finance)

Page 1 of 3

previousnext